Chemomab Therapeutics Ltd. (CMMB)
USD 1.59
(-3.64%)
USD 1.59
(-3.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -23.55 Million | -20.37 Million | -12.37 Million | -5.24 Million | -16.51 Million | -14.22 Million |
| Net Income | -24.15 Million | -27.64 Million | -12.47 Million | -5.95 Million | -27.21 Million | -13.79 Million |
| Depreciation & Amortization | 66.82 Thousand | 58 Thousand | 34 Thousand | 24 Thousand | 281.9 Thousand | 66 Thousand |
| Deferred income taxes | -2.79 Million | -2.96 Million | -912.63 Thousand | -579 Thousand | 2.81 Million | - |
| Stock-based compensation | 1.49 Million | 3.21 Million | 2.01 Million | 130 Thousand | 135 Thousand | 125 Thousand |
| Change in working capital | -945.55 Thousand | 4 Million | -1.94 Million | 555 Thousand | 4.62 Million | -3.42 Million |
| Other non-cash items | 2.78 Million | 2.96 Million | 912.63 Thousand | 579 Thousand | 2.96 Million | 6.27 Million |
| Investing Cash Flow | 15.83 Million | 19.53 Million | -45.18 Million | -62 Thousand | -95.3 Thousand | -213 Thousand |
| Investments in PPE | -2992.27 | -68 Thousand | -239 Thousand | -38 Thousand | -95.3 Thousand | -213 Thousand |
| Acquisitions | - | - | - | 136 Thousand | - | - |
| Investment purchases | - | - | -45.95 Million | -24 Thousand | - | - |
| Sales/Maturities of investments | 15.84 Million | 19.6 Million | - | -135.97 Thousand | - | - |
| Other Investing Activities | 0.27 | 19.6 Million | 1 Million | -24.00 | - | 2000.00 |
| Financing Cash Flow | 3.5 Million | -808 Thousand | 61.07 Million | 4.75 Million | 26.7 Million | 20.61 Million |
| Debt repayment | - | - | - | - | - | -17 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -1.21 Million | - | - | - | - |
| Common Stock Issuance | 3.49 Million | 267 Thousand | 58.63 Million | 3.5 Million | 26.7 Million | 20.6 Million |
| Other Financing Activities | 3.5 Million | 143 Thousand | 2.43 Million | 1.25 Million | 14.07 Million | 5.24 Million |
| Accounts receivables | 903.00 | -64.00 | -2058.00 | -99.00 | 2.31 Million | -3.49 Million |
| Accounts payables | -1.16 Million | 352 Thousand | 1.17 Million | 68 Thousand | 1.07 Million | 287 Thousand |
| Inventory | -903.00 | 64.00 | 2058.00 | 99.00 | - | - |
| Other working capital | 223.42 Thousand | 3.65 Million | -3.12 Million | 487 Thousand | 1.23 Million | -215 Thousand |
| Cash at beginning of period | 13.59 Million | 15.24 Million | 11.72 Million | 12.28 Million | 7.51 Million | 1.45 Million |
| Cash at end of period | 9.36 Million | 13.59 Million | 15.24 Million | 11.72 Million | 17.57 Million | 7.51 Million |
| Capital Expenditure | -2992.27 | -68 Thousand | -239 Thousand | -38 Thousand | -95.3 Thousand | -213 Thousand |
| Effect of forex changes on cash | -11 Thousand | - | - | - | -10.06 Million | - |
| Net cash flow / Change in cash | -4.22 Million | -1.64 Million | 3.51 Million | -554 Thousand | 10.05 Million | 6.06 Million |
| Free Cash Flow | -23.55 Million | -20.43 Million | -12.61 Million | -5.28 Million | -16.6 Million | -14.43 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.63 Million | -3.86 Million | -24.15 Million | -3.45 Million | -4.06 Million | -7.97 Million |
| Depreciation & Amortization | - | - | 66.82 Thousand | 16.17 Thousand | 18.93 Thousand | 16 Thousand |
| Deferred income taxes | - | - | -2.79 Million | -256.42 Thousand | -1.63 Million | -531.93 Thousand |
| Stock-based compensation | - | - | 1.49 Million | 238 Thousand | 130 Thousand | 639 Thousand |
| Change in working capital | - | - | -945.55 Thousand | -556.44 Thousand | -1.28 Million | -171 Thousand |
| Other non-cash items | 3.63 Million | 3.86 Million | 2.78 Million | 347.68 Thousand | 1.83 Million | 531.93 Thousand |
| Investing Cash Flow | - | - | 15.83 Million | 1.85 Million | 3.91 Million | -4.26 Million |
| Investments in PPE | - | - | -2992.27 | -29.46 | 6.93 | -2000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 15.84 Million | 1.85 Million | 3.91 Million | -4.26 Million |
| Other Investing Activities | - | - | 0.27 | 1.72 Million | 3.99 Million | -4266.00 |
| Financing Cash Flow | - | - | 3.5 Million | 2.14 Million | 5741.27 | 1.36 Million |
| Debt repayment | - | - | - | - | -5939.47 | -2967.56 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 3.49 Million | 2.14 Million | -198.20 | 1.35 Million |
| Other Financing Activities | - | - | 3.5 Million | 2.13 Million | 3000.00 | 1.36 Million |
| Accounts receivables | - | - | 903.00 | -71 Thousand | 163 Thousand | -3.00 |
| Accounts payables | - | - | -1.16 Million | -223.84 Thousand | -1.59 Million | 130 Thousand |
| Inventory | - | - | -903.00 | 71.00 | -163.00 | 3.00 |
| Other working capital | - | - | 223.42 Thousand | -332.59 Thousand | 315.47 Thousand | -301 Thousand |
| Cash at beginning of period | - | 9.36 Million | 13.59 Million | 9.22 Million | 10.45 Million | 20.84 Million |
| Cash at end of period | - | 9.36 Million | 9.36 Million | 9.36 Million | 9.22 Million | 10.45 Million |
| Capital Expenditure | - | - | -2992.27 | -29.46 | 6.93 | -2000.00 |
| Effect of forex changes on cash | - | - | -11 Thousand | 43.45 Thousand | -22.51 Thousand | - |
| Net cash flow / Change in cash | - | - | -4.22 Million | 140.19 Thousand | -1.22 Million | -10.38 Million |
| Free Cash Flow | - | - | -23.55 Million | -3.9 Million | -5.12 Million | -7.48 Million |
AW1
DNDDF
000885
ALFUW
RDX
HARIOMPIPE